People news

Share this article:
AstraZeneca named Rich Fante president of the company's US business. Fante will replace Tony Zook, who was recently named president of MedImmune, in addition to his position as CEO of AstraZeneca North America and head of global marketing. Fante was previously vice president, brand strategy & portfolio operations, and led marketing efforts for all AstraZeneca brands in the US.
 
Contract-sales firm PDI has appointed Nancy Lurker as CEO and member of the company's board of directors, effective Nov. 18. Lurker was previously senior vice president and CMO for Novartis Pharmaceuticals Corp., where she launched several products including Exforge, Tekturna, Reclast and the Exelon Patch.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media